Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus

被引：10

作者：

Dvorak, C. C. ^{[1
]}

Callard, E. ^{[1
]}

Agarwal, R. ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Div Pediat Stem Cell Transplantat, Palo Alto, CA 94304 USA

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 38卷 / 03期

关键词：

D O I：

10.1038/sj.bmt.1705422

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：253 / 254

页数：2

共 10 条

[1] IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine [J].

Ebo, DG ;

Piel, GC ;

Conraads, V ;

Stevens, WJ .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 87 (03) :243-245

[2] Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation [J].

Giaccone, L ;

McCune, JS ;

Maris, MB ;

Gooley, TA ;

Sandmaier, BM ;

Slattery, JT ;

Cole, S ;

Nash, RA ;

Storb, RF ;

Georges, GE .

BLOOD, 2005, 106 (13) :4381-4388

[3] Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation [J].

Jacobson, P ;

Rogosheske, J ;

Barker, JN ;

Green, K ;

Ng, J ;

Weisdorf, D ;

Tan, Y ;

Long, J ;

Remmel, R ;

Sawchuk, R ;

McGlave, P .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (05) :486-500

[4] Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: A 15-year experience [J].

Jamieson, CHM ;

Amylon, MD ;

Wong, RM ;

Blume, KG .

EXPERIMENTAL HEMATOLOGY, 2003, 31 (10) :981-986

[5]

Nash RA, 2000, BLOOD, V96, P2062

[6] A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation [J].

Nash, RA ;

Johnston, L ;

Parker, P ;

McCune, PS ;

Storer, B ;

Slattery, JT ;

Furlong, T ;

Anasetti, C ;

Appelbaum, FR ;

Lloid, ME ;

Deeg, HJ ;

Kiem, HP ;

Martin, PJ ;

Schubert, MM ;

Witherspoon, RP ;

Forman, SJ ;

Blume, KG ;

Storb, R .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (07) :495-505

[7] A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients [J].

Osunkwo, I ;

Bessmertny, O ;

Harrison, L ;

Cheung, YK ;

Van De Ven, C ;

del Toro, G ;

Garvin, J ;

George, D ;

Bradley, MB ;

Wolownik, K ;

Wischhover, C ;

Levy, J ;

Skerrett, D ;

Cairo, MS .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) :246-258

[8] A patient with anaphylactoid hypersensitivity to intravenous cyclosporine and subcutaneous phytonadione (vitamin K1) [J].

Riegert-Johnson, DL ;

Kumar, S ;

Volcheck, GW .

BONE MARROW TRANSPLANTATION, 2001, 28 (12) :1176-1177

[9] Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient [J].

Takamatsu, Y ;

Ishizu, M ;

Ichinose, I ;

Ogata, K ;

Onoue, M ;

Kumagawa, M ;

Suzumiya, J ;

Tamura, K .

BONE MARROW TRANSPLANTATION, 2001, 28 (04) :421-423

[10] Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review [J].

Volcheck, GW ;

Van Dellen, RG .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 80 (02) :159-163

← 1 →